Loss of peroxisome proliferator–activated receptor γ in mouse fibroblasts results in increased susceptibility to bleomycin‐induced skin fibrosis

Authors:

Abstract
Objective: There is increasing evidence that the transcription factor peroxisome proliferator–activated receptor γ (PPARγ) plays an important role in controlling cell differentiation, and that PPARγ ligands can modify inflammatory and fibrotic responses. The aim of the present study was to examine the role of PPARγ in a mouse model of skin scleroderma, in which mice bearing a fibroblast‐specific deletion of PPARγ were used.Methods: Cutaneous sclerosis was induced by subcutaneous injection of bleomycin, while untreated control groups were injected with phosphate buffered saline. Mice bearing a fibroblast‐specific deletion of PPARγ were investigated for changes in dermal thickness, inflammation, collagen content, and the number of α‐smooth muscle actin–positive cells. The quantity of the collagen‐specific amino acid hydroxyproline was also measured. In addition, the effect of PPARγ deletion on transforming growth factor β1 (TGFβ1) signaling in the fibroblasts was investigated.Results: Bleomycin treatment induced marked cutaneous thickening and fibrosis in all treated mice. Deletion of PPARγ resulted in enhanced susceptibility to bleomycin‐induced skin fibrosis, as indicated by increases in all measures of skin fibrosis and enhanced sensitivity of fibroblasts to TGFβ1 in PPAR‐deficient mice.Conclusion: These results indicate that PPARγ suppresses fibrogenesis. Specific agonists of PPARγ may therefore alleviate the extent of the development of cutaneous sclerosis.

This publication has 15 references indexed in Scilit: